Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Abstract Relapse remains the main cause of treatment failure in acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Emerging evidence has demonstrated that AML patients might benefit from maintenance therapy post-transplantation, especially for hig...

Full description

Bibliographic Details
Main Authors: Li Xuan, Qifa Liu
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Journal of Hematology & Oncology
Subjects:
Online Access:https://doi.org/10.1186/s13045-020-01017-7